-
Mesenchymal Stem Cell Therapy: Is There a Propensity for Cancer Development?
Aug 16, 2022 by Nathan Wick, DO, Tolga Suvar, MD, and Thomas Buchheit, MD; Regenerative SIG -
Prolotherapy: Background History, Mechanism of Action, and Current Evidence
Jul 29, 2022 by Yogesh Taheem, MD, and Tolga Suvar, MD -
Integrating Regenerative Therapies into Your Practice: Practical and Regulatory Considerations
Feb 11, 2022 by Thomas Buchheit, MD, Jason Eldrige, MD, and Christy Hunt, DO -
Prolotherapy: Review with background history, mechanism of action, and current evidence
Oct 15, 2021 by Regenerative Pain Medicine SIG -
Update for Healthcare Providers on the Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use
Feb 23, 2021 by Regenerative Pain Medicine SIG -
Regenerative Pain Medicine SIG Webcasts
Dec 22, 2020 by Regenerative Pain Medicine SIG -
Regenerative Medicine in the United States: The Current State and Future Outlook
Aug 7, 2019 by Corey Hunter, MD, and Yashar Eshraghi, MD